Using innovative research to drive new opportunities for lung treatments
In 1998, the year that Larry Page and Sergey Brin incorporated Google in Silicon Valley, Dr. Gerard Criner was working with a small team of biomedical engineers in a basement outside of San Francisco. The engineers and Criner, founding chair of the Department of Thoracic Medicine and Surgery at the Lewis Katz School of Medicine at Temple University, were trying to develop tools they hoped would transform the treatment of certain lung diseases. For decades, flexible fiber optic bronchoscopy was the… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - February 1, 2020 Category: Pharmaceuticals Authors: Temple Health Source Type: news

Robotics to Be the Driving Force Behind J & amp;J ’s Device Unit
Johnson & Johnson is offering a preview of its surgical robotics strategy  May 13th during its Medical Device Business Review Day in New York. Executives of the New Brunswick, NJ-based company announced the date during a call discussing its 4Q19 results on Wednesday. Alex Gorsky, J&J’s CEO noted that going forward surgical robotics would be a driving force behind the company’s medtech division. “As it relates to medical devices, we've been, I think, very consistent in sharing our thinking that, again, this next generation is certainly abo...
Source: MDDI - January 23, 2020 Category: Medical Devices Authors: Omar Ford Tags: Digital Health Source Type: news

J & amp;J Drops in Device Sales for 2019 Earnings
Johnson & Johnson is lagging when it comes down to device sales. The New Brunswick, NJ-based company shared earnings results that show medical device sales dipped about 3.8% from $25 billion to $26 billion for 2019. However, the firm saw growth in its pharmaceutical sales, which were up 3.6% to $42.2 billion. Overall, J&J reported 2019 Full-Year Sales of $82.1 billion reflecting growth of 0.6%, operational growth of 2.8% and adjusted operational growth of 4.5%. “We delivered strong underlying sales and earnings growth in 2019, driven by the strength of our Pharmaceutical business, accelerating per...
Source: MDDI - January 22, 2020 Category: Medical Devices Authors: Omar Ford Tags: Business Source Type: news

20 Private Companies to Watch in 2020
MD+DI has taken a hard look at the private medtech sector and developed this list of 20 private companies we will be paying particularly close attention to in the new year. It was not an easy task. There are so many interesting private companies in the industry right now that we started with a much longer list and whittled it down to the 20 companies that stood out most to us. So without further ado, here are the 20 companies that made the cut: 4C Medical is developing the AltaValve, a transcatheter mitral valve replacement (TMVR) platform designed to address mitr...
Source: MDDI - December 24, 2019 Category: Medical Devices Authors: Amanda Pedersen Tags: Business Source Type: news

20 Private Medtech Companies to Watch in 2020
MD+DI has taken a hard look at the private medtech sector and developed this list of 20 private companies we will be paying particularly close attention to in the new year. It was not an easy task. There are so many interesting private companies in the industry right now that we started with a much longer list and whittled it down to the 20 companies that stood out most to us. So without further ado, here are the 20 companies that made the cut: 4C Medical is developing the AltaValve, a transcatheter mitral valve replacement (TMVR) platform designed to address mitr...
Source: MDDI - December 24, 2019 Category: Medical Devices Authors: Amanda Pedersen Tags: Business Source Type: news

J & amp;J Fires up the Surgical Robotics Market with New Verb Deal
Earlier this year, MD+DI asked if Johnson & Johnson was becoming a surgical robotics powerhouse. This seems to be the case now that the New Brunswick, N.J.-based company has said it will acquire the remaining stake in the Verb Surgical joint venture it has with Verily. The companies did not disclose the financial details of deal, which is expected to close in the first half of 2020. In a release, J&J’s Worldwide Chairman, Medical Devices Ashley McEvoy said, "We have reached this important milestone thanks to the progress the Verb Surgical team has made with their digital surgery platform and ...
Source: MDDI - December 20, 2019 Category: Medical Devices Authors: Omar Ford Tags: Business Digital Health Source Type: news

Evaluation of Bronchoalveolar Lavage Fluid from Patients in an Outbreak of E-cigarette, or Vaping, Product Use-Associated Lung Injury - 10 States, August-October 2019
Bronchoscopy and bronchoalveolar lavage can be part of the clinical and diagnostic workup of e-cigarette, or vaping, product use-associated lung injury patients. (Source: CDC Morbidity and Mortality Weekly Report)
Source: CDC Morbidity and Mortality Weekly Report - November 14, 2019 Category: American Health Tags: Electronic Cigarettes (e-cigarette) Lung Health MMWR Morbidity & Mortality Weekly Report Outbreaks Flavorings-Related Lung Disease Source Type: news

Single-use flexible bronchoscopes cost  effective
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - November 1, 2019 Category: Drugs & Pharmacology Source Type: news

J & amp;J ’s Auris Has Solid Data to Support Monarch
Johnson & Johnson’s Auris Health revealed late-breaking data from the BENEFIT study during the CHEST 2019 Conference in New Orleans last week. BENEFIT is a study of the Monarch Platform, a robotic technology indicated for the use in diagnostic and therapeutic bronchoscopic procedures. BENEFIT assessed the safety and feasibility of using a robotic system to aid in the diagnosis of peripheral pulmonary lesions 1cm to 5 cm in size. During the study, investigators performed robotic-assisted bronchoscopy using the Monarch Platform on 55 patients across five study sites. The Monarch Platform localized targe...
Source: MDDI - October 26, 2019 Category: Medical Devices Authors: Omar Ford Tags: Software Source Type: news

New Tip-tracked Triple Needle Brush Helps Physician Take Samples to Assist in Early Diagnosis ...
Designed to sample lesions both inside and outside of an airway 180-degree SPiN Access Catheter used to gain access for biopsy and therapy delivery Allows bronchoscopist to utilize catheter-based approach with added benefits of advanced mapping, respiratory gating and tip-tracked instrument samplingThis story is related to the following:Catheters | (Source: Industrial Newsroom - Health, Medical and Dental Supplies)
Source: Industrial Newsroom - Health, Medical and Dental Supplies - October 23, 2019 Category: Medical Devices Source Type: news

J & amp;J Talks Up Surgical Robotics Plans
Few medtech sectors are as hot as surgical robotics is right now, so it comes as no surprise that analysts tried to dig for information about Johnson & Johnson's plans for the market during the company's third-quarter earnings call Tuesday. "I couldn't be more bullish around how J&J is going to create value in this space," Ashley McEvoy, EVP and worldwide chairman of Johnson & Johnson's medical device segment, said during the call in response to an analyst's question about surgical robotics. "The goal that we're trying to achieve is really to make medical interventions smarter, less invasive, mor...
Source: MDDI - October 15, 2019 Category: Medical Devices Authors: Amanda Pedersen Tags: Business Source Type: news

Tooth aspiration in a patient with traumatic brain injury - Pantazopoulos I, Kokkoris S, Routsi C.
Tooth aspiration is a rare issue in the course of patients with trauma and may remain undiagnosed for a long period, resulting in delayed complications, such as atelectasis and recurrent infections. Flexible bronchoscopy is considered the preferred primary... (Source: SafetyLit)
Source: SafetyLit - October 7, 2019 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news

Can Radiolucent Foreign Bodies Be Identified?
Discussion Foreign bodies are common problems for young children particularly ages 2-4 years who will mouth many objects and aspirate or swallow them. Children will also place foreign objects in other body orifices such as ears or noses. It is also not uncommon that young girls will inadvertently have toilet paper caught in the vaginal area during hygiene. Many of these foreign bodies may work their way out naturally not causing any problems, or may come to attention later because of chronic problems such as a foul-smell or discharge. Older children may tell adults that they have placed a foreign body in an orifice and thu...
Source: PediatricEducation.org - October 7, 2019 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news

Examining the Role of Bronchoscopy in Patients with Hematological Malignancies
Conference abstracts (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - September 22, 2019 Category: Respiratory Medicine Authors: MeganB Source Type: news

AI Provides a Detailed Road Map for Interventional Lung Procedures
Precise medical imaging and analysis could enable early detection of lung cancer, help determine its exact size and location, and significantly improve diagnosis and treatment. This is usually done in a process called segmentation, which uses computers to identify the boundaries of the lung from surrounding thoracic tissue on CT images. From this process, a detailed 3-D map of the airways may be generated that can help to plan and navigate a bronchoscopy procedure to obtain biopsy samples and to perform other clinical interventions. “Until now, t...
Source: MDDI - August 23, 2019 Category: Medical Devices Authors: Susan Shepard Tags: Imaging Source Type: news

Intuitive Is the Latest Surgical Robotics Company to Level Up
There’s no doubt that the surgical robotics market is getting more crowded the competition is increasing. Intuitive Surgical, a pioneer in the space, is well aware of this fact and took steps this week to boost the da Vinci surgical robot. For an undisclosed sum, the Sunnyvale, CA-based company said it is acquiring the robotic endoscope portion of Schölly Fiberoptic’s business. Schölly Fiberoptic is a player in the field of visualization systems for minimally invasive diagnostic and surgical applications, headquartered in Germany — and one of I...
Source: MDDI - July 17, 2019 Category: Medical Devices Authors: Omar Ford Tags: Business Digital Health Source Type: news

Using electromagnetic navigation bronchoscopy (ENB) to diagnose fungal infections.
Tue, 07/16/2019 - 14:41News blog (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - July 16, 2019 Category: Respiratory Medicine Authors: helenfindon Source Type: news

BENEFIT Results Could Contain Spoilers for Monarch ’s Effectiveness
Johnson & Johnson’s Auris Health scored positive preliminary results from a first-in-human study evaluating the Monarch Platform to aid in the diagnosis of peripheral pulmonary lesions. Data from the BENEFIT study was presented at the American Thoracic Society 2019 Conference in Dallas. So far in BENEFIT, Monarch has been used in 24 patients to localize targeted nodules using a combination of direct visualization, navigational guidance and radial endobronchial ultrasound. The primary effectiveness endpoint, successful localization of targeted pulmonary lesions confirmed using a radial endobronchial ul...
Source: MDDI - May 20, 2019 Category: Medical Devices Authors: Omar Ford Tags: Digital Health Source Type: news

Tracheo-oesophageal fistula in a case of button battery ingestion: CT virtual bronchoscopy imaging - Agarwal SS, Shetty DS, Joshi MV, Manwar SU.
Foreign body ingestion in paediatric population is a very common problem. Usually the foreign bodies pass through the gastrointestinal tract without any complications; however, certain foreign bodies like button batteries might cause severe injuries like t... (Source: SafetyLit)
Source: SafetyLit - May 17, 2019 Category: International Medicine & Public Health Tags: Age: Infants and Children Source Type: news

J & amp;J & #039;s Ethicon Spends $400M for Takeda ’s Fibrin Sealant Patch
Johnson & Johnson’s Ethicon is set to acquire Takeda Pharmaceutical’s Fibrin Sealant Patch for $400 million. The deal is set to close in the second half of 2019. The TachoSil is a surgical patch designed to achieve safe fast and reliable bleeding control. Upon close, about 80 employees will transition to Ethicon. Takeda said net sales for TachoSil were about $155 million for the 2018 fiscal year. Terms for the deal call for Ethicon to acquire the assets and licenses that support the manufacturing, licensing and commercialization of TachoSil, while Takeda maintains ownership of the ma...
Source: MDDI - May 9, 2019 Category: Medical Devices Authors: Omar Ford Tags: Business Source Type: news

Digital Health Plays Larger Role in MDEA for 2019
For more than 20 the Medical Design Excellence Awards have celebrated medtech products that improve the quality of healthcare and accessibility. From prosthetic legs to breast pumps, over the years, MDEA has always been a spotlight of the greatest innovation in medtech. This year was no different – with a wide variety of innovations coming from all segments of medtech. Just like any other year, jurors from all over the country shuffled into a conference room at the Anaheim Convention Center to see which products would be finalists for the MDEA. One trend seemed to stand out – the increas...
Source: MDDI - April 30, 2019 Category: Medical Devices Authors: Omar Ford Tags: Design News Source Type: news

Eisenhower Health first in Southern California to offer landmark treatment for COPD/emphysema
(Pulmonx) Eisenhower Health is the first hospital in Southern California to offer a new lung valve treatment for patients with severe COPD/emphysema. The Zephyr Endobronchial Valve treatment represents a major advancement because it is the first minimally invasive procedure to help emphysema sufferers breathe easier without major surgery. Done through a simple bronchoscopy, the valves improve patients' quality of life by allowing them to breathe easier, be less short of breath, and be more active and energetic. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 24, 2019 Category: International Medicine & Public Health Source Type: news

Lawsuits Put a Drag on J & amp;J 1Q19 Earnings
Legal costs surrounding Johnson and Johnson’s talc baby power and its blood thinner Xarleto bogged down the healthcare giant’s 1Q19 earnings. But while earnings from the New Brunswick, NJ-based company were down 14% from a year earlier, the firm managed to beat analyst expectations. J&J posted income of $3.75 billion or $1.39 per share for 1Q19. In 1Q18, the company brought in $4.37 billion or $1.60 per share. As a result, the healthcare company changed its full-year earnings forecast to a range of $8.53 to $8.63 a share, down from its previous estimate of between $8.50 and $8.65. Th...
Source: MDDI - April 16, 2019 Category: Medical Devices Authors: Omar Ford Tags: Business Source Type: news

Johnson & Johnson closes Auris Health buyout, sterilization biz sale
Johnson & Johnson (NYSE:JNJ) said yesterday that its Ethicon biz completed its $3.4 billion acquisition of robotic surgery dev Auris Health and the $2.8 billion divestiture of its Advanced Sterilization Products to Fortive (NTSE:FTV). Redwood City, Calif.-based Auris Health, which was created by Intuitive Surgical (NSDQ:ISRG) founder and surgical robotics pioneer Dr. Fred Moll, developed and produces the robotic Monarch platform which has FDA clearance for diagnostic and therapeutic bronchoscopic procedures. The Monarch system features a controller interface for navigating the integrated flexible ro...
Source: Mass Device - April 2, 2019 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Featured Mergers & Acquisitions Robotics Sterilization / Calibration Wall Street Beat johnsonandjohnson Source Type: news

FDA clears Mauna Kea Technologies system for lung cancer detection
Mauna Kea Technologies’ Cellvizio system Paris-based Mauna Kea Technologies (ENT:MKEA) said that it has received  510(k) clearance from FDA for the use of the Cellvizio AQ-Flex 19 Confocal Miniprobe through existing bronchoscopes, transbronchial needles, and other bronchoscopic accessories to detect lung cancer. Cellvizio is a multidisciplinary probe-based and needle-based confocal laser endomicroscopy (pCLE/nCLE) platform designed to aid clinicians in the diagnosis and treatment of cancer and other diseases using real-time, in vivo microscopic visualization, according to the company. This ma...
Source: Mass Device - February 26, 2019 Category: Medical Devices Authors: Nancy Crotti Tags: 510(k) Blog Diagnostics Food & Drug Administration (FDA) Imaging News Well Oncology Regulatory/Compliance Mauna Kea Technologies Source Type: news

Is J & amp;J Becoming a Surgical Robotics Powerhouse?
Johnson & Johnson is making some significant noise in the surgical robotics space today as it is announcing a deal that would have it acquire Auris Health for $3.4 billion. The deal also calls for additional contingent payments of up to $2.35 billion in the event of Auris reaching certain milestones. J&J would make the acquisition through its Ethicon subsidiary. Redwood City, CA-based Auris Health develops robotic technologies that have been focused on lung cancer. The firm has the Monarch Platform, an FDA cleared system currently used in bronchoscopic diagnostic and therapeutic procedures. In November of 2018, Aur...
Source: MDDI - February 14, 2019 Category: Medical Devices Authors: Omar Ford Tags: Business Digital Health Source Type: news

PETA: Cincinnati Children ’s agrees to halt use of live cats to train doctors
Cincinnati Children ’s Hospital executives ordered that live cats no longer be used to teach human bronchoscopy and intubation techniques to doctors from around the world, apparently following a complaint from People for the Ethical Treatment of Animals. Physicians who teach a pediatric flexible bronchoscopy post-gr aduate course will no longer use animals, according to a Feb. 8 letter sent to PETA by Dr. Margaret Hostetter, chair of the Department of Pediatrics at Cincinnati’s largest hospital. Hostetter… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - February 13, 2019 Category: American Health Authors: Barrett J. Brunsman Source Type: news

Johnson & Johnson delves into robotics, buys Auris Health for $3.4 billion
Johnson& Johnson, one of the largest maker of health products, is now in the robotics space. The New Brunswick, New Jersey-based company announced Wednesday that it would buy surgery firm Auris Health for $3.4 billion in cash. Auris Health is a privately held developer of robotic technologies, initially focused in lung cancer, with an FDA-cleared platform currently used in bronchoscopic diagnostic and therapeutic procedures. This latest deal is expected to bolster Johnson& Johnson ’s entry… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - February 13, 2019 Category: Biotechnology Source Type: news

Johnson and Johnson Announces Agreement to Acquire Auris Health, Inc.
Auris Health's Robotic Platform Expands Johnson & Johnson's Digital Surgery Portfolio NEW BRUNSWICK, N.J., Feb. 13, 2019 -- (Healthcare Sales & Marketing Network) -- Focused on creating the next frontier of surgery, Johnson & Johnson (NYSE: JNJ), today... Devices, Mergers & Acquisitions Johnson & Johnson, Auris Health, bronchoscopy, robotic (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 13, 2019 Category: Pharmaceuticals Source Type: news

J & J to enter the robotic surgery market with $3.4B Auris Health buy
Johnson & Johnson (NYSE:JNJ) is stepping into the field of robotic surgery after saying today that its Ethicon subsidiary inked a $3.4 billion deal to pick up surgical robotics pioneer Dr. Fred Moll’s newest robotic surgical play, Auris Health, and its FDA-cleared Monarch platform. The New Brunswick, N.J.-based medtech giant said that the deal will include an additional $2.35 billion in milestone-based contingent payments, bringing the total value of the deal to approximately $5.75 billion. Redwood City, Calif.-based Auris Health’s robotic Monarch platform has FDA clearance for diagnostic and ther...
Source: Mass Device - February 13, 2019 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Featured Mergers & Acquisitions Robotics Wall Street Beat aurishealth johnsonandjohnson Source Type: news

New assay selects patients with lung cancer for treatment with immune checkpoint inhibitors
(Elsevier) A report in The Journal of Molecular Diagnostics describes a novel and rapid approach for quantifying PD-L1 expression levels in tumors that requires only small amounts of tissue that can be collected using minimally invasive bronchoscopy techniques. This approach can also be used to discriminate malignant from benign tumors and identify mutational status, all of which can guide and refine therapeutic decisions. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 13, 2019 Category: International Medicine & Public Health Source Type: news

Why Was This Nonsmoker Coughing for Months?
(MedPage Today) -- COPD inhaler didn't help, but bronchoscopy did (Source: MedPage Today Pulmonary)
Source: MedPage Today Pulmonary - February 4, 2019 Category: Respiratory Medicine Source Type: news

Real-World Data on Medtronic & #039;s Lung Cancer Device Is Promising
Recently published results of a large, multicenter trial could go a long way toward boosting adoption of electromagnetic navigation bronchoscopy (ENB) procedures using Medtronic's superDimension navigation system to aid in lung cancer diagnosis, staging, and treatment. The 12-month results of the NAVIGATE study were published in the Journal of Thoracic Oncology. "It's not enough anymore to just make a really amazing new technology, it has to be backed with clinical and economic evidence and one that allows really broad adoption around the globe to really impact as many patients as we can," Emily Elswi...
Source: MDDI - January 31, 2019 Category: Medical Devices Authors: Amanda Pedersen Tags: Business Source Type: news

Medtronic touts U.S. results of lung cancer detection trial
Partial results of a huge, real-world study of Medtronic’s (NYSE:MDT) superDimension LungGPS technology found that 65% of patients diagnosed with primary lung cancer (Stages I and II) were at early stages of the disease. Early detection of lung cancer is critical to improving patient outcomes long-term. The results came from a 12-month follow-up of the 1,215-patient U.S. portion of the Navigate trial. Begun in 2015, the trial was designed to evaluate the performance of the LungGPS electromagnetic navigation bronchoscopy (ENB) technology that the superDimension device uses to navigate the lungs. Results...
Source: Mass Device - January 30, 2019 Category: Medical Devices Authors: Nancy Crotti Tags: Blog Clinical Trials Featured Oncology Covidien journalofthoraciconcology Medtronic Source Type: news

J & J may nab surgical robotics company Auris Health
Johnson & Johnson (NYSE:JNJ) intends to acquire surgical robotics company Auris Health, according to a report by Bloomberg News. In May 2018, Auris inked an agreement with J&J’s division Ethicon’s NeuWave Medical subsidiary to develop systems for the robotically-assisted bronchoscopic ablation of lung lesions. J&J has been working with Alphabet‘s (NSDQ:GOOGL) Verily Life Sciences on Verb Surgical’s prototype robot-assisted surgery platform. J&J wants to spend more for Auris than the smaller company’s $2 billion valuation from its latest funding round, t...
Source: Mass Device - January 23, 2019 Category: Medical Devices Authors: Nancy Crotti Tags: Blog Business/Financial News Endoscopic / Arthroscopic Mergers & Acquisitions Robotics aurishealth johnsonandjohnson Source Type: news

Olympus announces Spiration bronchial valve launch
The Spiration valve is an umbrella-shaped device that a health provider places in a targeted airway of the lung during a short bronchoscopic procedure. [Image courtesy of Olympus]Olympus’  Spiration bronchial valve for the treatment of severe emphysema is now available on the market, the company  (TYO:7733) said today. The announcement came a little over a year after FDA approval of Spiration, which was designated as a breakthrough medical device. Spiration also has regulatory approval in the E.U., Australia and New Zealand. Get the full story on our sister site Medical Design & Outsourci...
Source: Mass Device - January 22, 2019 Category: Medical Devices Authors: Chris Newmarker Tags: Business/Financial News News Well emphysema Olympus Source Type: news

Penn Highlands Healthcare first in the region to offer first FDA-approved lung valve for patients with severe COPD/emphysema
(Pulmonx) Penn Highlands Healthcare is the first medical facility in the region to offer bronchoscopic lung volume reduction using the first lung valve approved by the US Food and Drug Administration for helping emphysema patients breathe easier without major surgery. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 8, 2019 Category: International Medicine & Public Health Source Type: news

Foreign body aspiration of the lower airways in children - diagnosis in clinical practice - Hajnal D, Kov ács T.
INTRODUCTION AND AIM: Rigid bronchoscopic foreign body removal is the gold standard procedure for foreign body aspiration. We have analysed our results of bronchoscopies and the accuracy of diagnosis among the paediatric population in Southeast Hungary. ... (Source: SafetyLit)
Source: SafetyLit - December 19, 2018 Category: International Medicine & Public Health Tags: Age: Infants and Children Source Type: news

National Institute for Health and Care Excellence (NICE) issues new guidelines for COPD
(Pulmonx) NICE makes a 'strong' recommendation that patients with severe COPD be referred for evaluation for bronchoscopic lung volume reduction, including the Zephyr ® Endobronchial Valve System.NICE has broadened the criteria for evaluation and a new group of people for whom lung volume reduction surgery was unsuitable may now be evaluated for treatment with Zephyr Valves, a less invasive treatment option. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 11, 2018 Category: International Medicine & Public Health Source Type: news

Olympus wins FDA nod for Spiration bronchial valve
Olympus (TYO:7733) said yesterday that it won FDA approval for its Spiration Valve System intended to treat severe emphysema, which was designated as a breakthrough medical device. The Spiration Valve is an umbrella shaped device intended to improve breathing by blocking airflow to diseased portions of the lung, the Tokyo-based company said. The device is placed during a bronchoscopic procedure to reduce lung volume in diseased lung sections and allow healthier tissue in the remaining portion of the lung to function better. Approval of the device came based on the results from the Emprove clinical trial of the SV...
Source: Mass Device - December 6, 2018 Category: Medical Devices Authors: Fink Densford Tags: Food & Drug Administration (FDA) Regulatory/Compliance Respiratory Olympus Source Type: news

Auris Scores Big with $200M Raise for Robotics Platform
The robotics market is surging. Auris Health recent raise of $200 million to commercialize the Monarch Platform is a perfect example. The Redwood City, CA-based company has raised more than $700 million to develop and commercialize the Monarch platform - a robotic system that enables more-accurate diagnosis and treatment of small and hard-to-reach nodules in the periphery of the lung. Monarch received FDA clearance for Monarch to perform diagnostic and therapeutic bronchoscopic procedures earlier this year. The platform uses a familiar controller interface to navigate a flexible robotic endoscope to the periphery of the lu...
Source: MDDI - November 30, 2018 Category: Medical Devices Authors: Omar Ford Tags: Business Source Type: news

Auris Health closes $220m equity funding round
Auris Health said today that it closed a $220 million equity financing round to help support its next-generation Monarch robotic interventional platform. The Redwood City, Calif.-based company said that the round was led by Partner Fund Management and joined by newly invested Wellington Management, D1 Capital Partners and Senator Investment Group and existing investors Mithril Capital, Lux Capital and Viking Global Investors. The funding round brings the total raised for its Monarch surgical platform up to $700 million, Auris Health said. “The support of this group of world-class investors will be instrumental as Aur...
Source: Mass Device - November 28, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Featured Robotics Wall Street Beat aurishealth Source Type: news

Pulmonx wins Aetna coverage for Zephyr endobronchial valve
Pulmonx said yesterday that it won national coverage through health insurer Aetna for its Zephyr endobronchial valve system intended for treating severe emphysema and chronic obstructive pulmonary disorder. The coverage will make the Zephyr valve available to Aetna’s 22 million members, the Redwood City, Calif.-based company said. Under its new policy, Aetna specifically named the Zephyr as an approved bronchoscopic option for lung volume reduction, considering it medically necessary for the broncoscopic treatment of adult patients with hyperinflation associated with severe emphysema in regions of the lung with littl...
Source: Mass Device - November 15, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Respiratory Pulmonx Source Type: news

Bronchoscopy
(Source: eMedicineHealth.com)
Source: eMedicineHealth.com - October 22, 2018 Category: General Medicine Source Type: news

Auris Health touts robotically-assisted bronchoscopy study results
Auris Health’s Monarch bronchoscopy platform reached lung nodules and biopsied tissue with “high accuracy” in a recent study, according to the company. Eight investigators performed robotic-assisted bronchoscopy procedures using the Monarch platform on a cadaveric model designed to mimic a real-life bronchoscopy procedure. Sixty-seven simulated tumor targets one to three centimeters in size were prepared in eight human cadaveric lungs. The tissue acquired during the bronchoscopy was evaluated and correctly identified as the implanted target in 97% of cases, the study noted. Auris presented the results of ...
Source: Mass Device - October 15, 2018 Category: Medical Devices Authors: Nancy Crotti Tags: Blog Featured Oncology Robotics aurishealth johnsonandjohnson Source Type: news

Finding Lung Cancer Outside the Airways Just Got Easier
Diagnosing solitary lung tumors located outside of a patient's main airways has long been a challenge, but evidence is building around a technology designed to improve access to such tumors. According to data unveiled this week at the European Respiratory Society International Congress in Paris, Broncus Medical's Archimedes virtual bronchoscopy navigation system helped to more than double the diagnostic yield for nodules with negative bronchus sign or an airway leading to the nodule. The six-year-old, San Jose, CA-based company said the Archimedes System is the only system of its kind offering real-...
Source: MDDI - September 17, 2018 Category: Medical Devices Authors: Amanda Pedersen Tags: Imaging Source Type: news

New Bronchoscopic Option Used for Severe Emphysema
First bronchoscopic lung volume reduction using endobronchial valve performed at Temple University (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - September 10, 2018 Category: Respiratory Medicine Tags: Pulmonology, Surgery, Institutional, Source Type: news

New Bronchoscopic Option Used for Severe Emphysema
MONDAY, Sept. 10, 2018 -- Temple University Hospital has become the first center in the U.S. to perform bronchoscopic lung volume reduction using implantation of the Zephyr Endobronchial Valve (Zephyr EBV) to treat hyperinflation associated with... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 10, 2018 Category: Pharmaceuticals Source Type: news

Body Vision raises $8.5 million to market cancer diagnostic system in U.S.
Body Vision Medical said today it has landed $8.5 million in funding to accelerate the commercialization of its LungVision lung navigation system in the U.S. and to extend its product line. The Ramat Ha Sharon, Israel-based company specializes in lung cancer diagnostics through augmented real-time intra-body navigation and imaging. Its catheter is designed for use in conjunction with standard bronchoscopes and its LungVision system for guiding endotherapy accessories to small pulmonary nodules.  LungVision’s catheter won FDA clearance in April. Its imaging and navigation system was cleared in May 2017. &ldq...
Source: Mass Device - September 5, 2018 Category: Medical Devices Authors: Nancy Crotti Tags: Blog Business/Financial News Catheters Diagnostics Oncology Body Vision Medical Source Type: news

Temple University Hospital performs nation's 1st post-FDA approval BLVR using Zephyr Valve
(Temple University Health System) Temple University Hospital has become the first US center to perform bronchoscopic lung volume reduction using implantation of the Zephyr ® Endobronchial Valve (Zephyr ® EBV ® ) to treat severe emphysema following US FDA approval. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 20, 2018 Category: International Medicine & Public Health Source Type: news